BioSpace News Archive

Burning Rock Biotech Limited announced that all shareholder resolutions proposed at the Company’s 2023 annual general meeting held today were duly passed.

Schrödinger, Inc. today reported that on December 13, 2023, the company granted (i) non-statutory stock options to purchase 1,800 shares of the company’s common stock to three newly hired employees and (ii) restricted stock units (RSUs) with respect to 2,250 shares of the company’s common stock to three newly hired employees.

On November 21, 2023, FOXO Technologies Inc., a Delaware corporation (the “ Company ”), received an official notice of noncompliance.

The Scleroderma Research Foundation, the nation’s largest non-profit funder of scleroderma research, announced that the FDA has cleared its Investigational New Drug application to launch the CONQUEST clinical trial platform and begin enrolling patients.

The Midwest Bioprocessing Center (MBC), a leading producer of biobased chemicals for human health, nutrition, and personal care announced that it has been awarded a $1.8MM

Acentra Health, a leading provider of clinical services and technology solutions to government healthcare agencies, announced that Kepro has received full accreditation from URAC in Disease Management.

Quest Diagnostics today unveiled its new confirmatory testing service for novel psychoactive substances.

Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities in December at Cell Bio 2023, the annual meeting of the American Society for Cell Biology.

Cadrenal Therapeutics, Inc. announced that Noble Capital Markets has initiated equity research coverage on the Company with an “Outperform” rating and a price target of US$4.00 per share.

DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 42nd annual J.P. Morgan Healthcare Conference on January 8, 2024.